IUB PRIMA
Hormonal Intrauterine Ball
- User: Female
- Hormonal: Hormonal
-
Delivery type:
- Intrauterine
-
Intended Duration:
- Long-Acting
- Development Stage: Pre-Clinical
- Developer(s)/researcher(s): OCON Medical Ltd.
Details
- API: Progestin
- Target: Progesterone Receptor
-
Mechanism of Action:
- Ovulation Inhibition
- Cervical Mucus Changes
- Endometrial Changes
- Inactive Materials: Nitinol (Nickel and Titanium Composite Material) Wire
- Regimen: 1 Insertion/TBD Years
- MPT: Not Potential MPT
- Promising Attributes: The sphere shape of the IUB is intended to minimize pain and risk of perforation or expulsion. Like other IUDs, the hormone-loaded IUD may have both contraceptive and therapeutic indications.
Product Status
Developer Pipeline Indicates Intent to Pursue Near-Future Clinical Research
History
2022: OCON Healthcare announces development of IUB Prima, a hormone-loaded version of their product IUB Ballerine
2024: OCON announces a successful investment round to advance IUB Prima beyond the concept stage